MA H945 | 2023-2024 | 193rd General Court
Note: Legislation replaced by H4634
Status
Spectrum: Moderate Partisan Bill (Democrat 27-2-1)
Status: Introduced on February 16 2023 - 25% progression
Action: 2024-05-09 - Accompanied a study order, see H4634
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 16 2023 - 25% progression
Action: 2024-05-09 - Accompanied a study order, see H4634
Text: Latest bill text (Introduced) [PDF]
Summary
For legislation to ensure prescription drug cost transparency and affordability. Financial Services.
Title
To ensure prescription drug cost transparency and affordability
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-05-09 | House | Accompanied a study order, see H4634 |
| 2024-02-22 | House | Reported favorably by committee and referred to the Joint Committee on Health Care Financing |
| 2023-05-02 | Joint | Hearing scheduled for 05/16/2023 from 10:00 AM-01:00 PM in A-2 and virtual |
| 2023-02-16 | Senate | Senate concurred |
| 2023-02-16 | House | Referred to the Joint Committee on Financial Services |
Same As/Similar To
H4634 (Replaced by) 2024-05-09 - Reported, in part, by H962
H1056 (Similar To) 2024-05-30 - Accompanied a study order, see H4691
H1056 (Similar To) 2024-05-30 - Accompanied a study order, see H4691
Massachusetts State Sources
| Type | Source |
|---|---|
| Summary | https://malegislature.gov/Bills/193/H945 |
| Text | https://malegislature.gov/Bills/193/H945.pdf |
